USIBC and Section 3(d): Incremental Intelligence?
A recent USIBC report on section 3(d) has caused a great deal of controversy, with public health groups decrying the presence of Commerce Minister, Anand Sharma at the inaugural function announcing this report. Priyanka Gollikeri of DNA has an interesting report documenting this controversy, where she notes: “The US study, a copy of which is with this newspaper, argues that incremental innovations can lead to a decrease in costs and increased access to drugs by reducing overall treatment costs and […]
USIBC and Section 3(d): Incremental Intelligence? Read More »




